(Q38422779)

3 September 2017

title

Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study (English)

1 reference

3 September 2017

1 reference

Jorge L Yao

1

1 reference

3 September 2017

Charlotte K Ryan

2

1 reference

3 September 2017

Charles W Francis

3

1 reference

3 September 2017

Manish Kohli

4

1 reference

3 September 2017

Mark B Taubman

5

1 reference

3 September 2017

Alok A Khorana

6

1 reference

3 September 2017

language of work or name

1 reference

1 May 2009

1 reference

3 September 2017

1 reference

3 September 2017

volume

27

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

430-434

1 reference

Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Tissue factor, thrombin, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Tissue factor expression and prognosis in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

The hemostatic system as a regulator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

The role of tissue factor pathway inhibitor-2 in cancer biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Prostasomes, angiogenesis, and tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Pharmacological inhibition of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900802527247

10.1080/07357900802527247

21 January 2018

Identifiers

DOI

1 reference

release_msplvmh3hnb7jeubl7wrn5k34q

3 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/msplvmh3hnb7jeubl7wrn5k34q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference